{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:11:44Z","timestamp":1790007104025,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T00:00:00Z","timestamp":1430697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1038\/leu.2015.114","type":"journal-article","created":{"date-parts":[[2015,5,4]],"date-time":"2015-05-04T06:41:53Z","timestamp":1430721713000},"page":"2003-2014","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL"],"prefix":"10.1038","volume":"29","author":[{"given":"E","family":"Vasyutina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M","family":"Boucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bloehdorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Aszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Crispatzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Stiefelhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Beutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hallek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Herling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,4]]},"reference":[{"key":"BFleu2015114_CR1","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi R, Shinton SA, Martin ES, Koval A, Calin GA, Cesari R et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci USA 2002; 99: 6955\u20136960.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/sj.leu.2404017","volume":"20","author":"M Herling","year":"2006","unstructured":"Herling M, Patel KA, Khalili J, Schlette E, Kobayashi R, Medeiros LJ et al. TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state. Leukemia 2006; 20: 280\u2013285.","journal-title":"Leukemia"},{"key":"BFleu2015114_CR3","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1182\/blood-2009-03-208256","volume":"114","author":"M Herling","year":"2009","unstructured":"Herling M, Patel KA, Weit N, Lilienthal N, Hallek M, Keating MJ et al. High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia. Blood 2009; 114: 4675\u20134686.","journal-title":"Blood"},{"key":"BFleu2015114_CR4","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1073\/pnas.97.7.3028","volume":"97","author":"Y Pekarsky","year":"2000","unstructured":"Pekarsky Y, Koval A, Hallas C, Bichi R, Tresini M, Malstrom S et al. Tcl1 enhances Akt kinase activity and mediates its nuclear translocation. Proc Natl Acad Sci USA 2000; 97: 3028\u20133033.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR5","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1097-2765(00)00039-3","volume":"6","author":"J Laine","year":"2000","unstructured":"Laine J, K\u00fcnstle G, Obata T, Sha M, Noguchi M . The protooncogene TCL1 is an Akt kinase coactivator. Mol Cell 2000; 6: 395\u2013407.","journal-title":"Mol Cell"},{"key":"BFleu2015114_CR6","doi-asserted-by":"publisher","first-page":"19643","DOI":"10.1073\/pnas.0810965105","volume":"105","author":"Y Pekarsky","year":"2008","unstructured":"Pekarsky Y, Palamarchuk A, Maximov V, Efanov A, Nazaryan N, Santanam U et al. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci USA 2008; 105: 19643\u201319648.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR7","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1038\/leu.2012.63","volume":"26","author":"M Sivina","year":"2012","unstructured":"Sivina M, Hartmann E, Vasyutina E, Boucas JM, Breuer A, Keating MJ et al. Stromal cells modulate TCL1 expression, interacting AP-1 components and TCL1-targeting micro-RNAs in chronic lymphocytic leukemia. Leukemia 2012; 26: 1812\u20131820.","journal-title":"Leukemia"},{"key":"BFleu2015114_CR8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1182\/blood-2011-08-374561","volume":"119","author":"E Gaudio","year":"2012","unstructured":"Gaudio E, Spizzo R, Paduano F, Luo Z, Efanov A, Palamarchuk A et al. Tcl1 interacts with Atm and enhances NF-\u03baB activation in hematologic malignancies. Blood 2012; 119: 180\u2013187.","journal-title":"Blood"},{"key":"BFleu2015114_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1182\/blood-2007-07-101519","volume":"111","author":"M Herling","year":"2008","unstructured":"Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood 2008; 111: 328\u2013337.","journal-title":"Blood"},{"key":"BFleu2015114_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.leukres.2004.07.012","volume":"29","author":"SR Fink","year":"2005","unstructured":"Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD et al. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res 2005; 29: 253\u2013262.","journal-title":"Leuk Res"},{"key":"BFleu2015114_CR11","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006; 66: 11590\u201311593.","journal-title":"Cancer Res"},{"key":"BFleu2015114_CR12","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/leu.2009.125","volume":"23","author":"B Cardinaud","year":"2009","unstructured":"Cardinaud B, Moreilhon C, Marcet B, Robbe-Sermesant K, LeBrigand K, Mari B et al. miR-34b\/miR-34c: a regulator of TCL1 expression in 11q- chronic lymphocytic leukaemia? Leukemia 2009; 23: 2174\u20132177.","journal-title":"Leukemia"},{"key":"BFleu2015114_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature07242","volume":"455","author":"D Baek","year":"2008","unstructured":"Baek D, Vill\u00e9n J, Shin C, Camargo FD, Gygi SP, Bartel DP . The impact of microRNAs on protein output. Nature 2008; 455: 64\u201371.","journal-title":"Nature"},{"key":"BFleu2015114_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.beha.2007.02.003","volume":"20","author":"GA Calin","year":"2007","unstructured":"Calin GA, Pekarsky Y, Croce CM . The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007; 20: 425\u2013437.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu2015114_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2119\/molmed.2013.00005","volume":"19","author":"N Papakonstantinou","year":"2013","unstructured":"Papakonstantinou N, Ntoufa S, Chartomatsidou E, Papadopoulos G, Hatzigeorgiou A, Anagnostopoulos A et al. Differential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemia. Mol Med 2013; 19: 115\u2013123.","journal-title":"Mol Med"},{"key":"BFleu2015114_CR16","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3109\/10428194.2013.796055","volume":"54","author":"M Mraz","year":"2013","unstructured":"Mraz M, Kipps TJ . MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia. Leuk Lymphoma 2013; 54: 1836\u20131839.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2015114_CR17","doi-asserted-by":"publisher","first-page":"15524","DOI":"10.1073\/pnas.242606799","volume":"99","author":"GA Calin","year":"2002","unstructured":"Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524\u201315529.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/leu.2012.211","volume":"27","author":"M Konantz","year":"2013","unstructured":"Konantz M, Andr\u00e9 MC, Ebinger M, Grauer M, Wang H, Grzywna S et al. EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia 2013; 27: 56\u201365.","journal-title":"Leukemia"},{"key":"BFleu2015114_CR19","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1182\/blood-2012-11-466250","volume":"121","author":"O Fedorchenko","year":"2013","unstructured":"Fedorchenko O, Stiefelhagen M, Peer-Zada AA, Barthel R, Mayer P, Eckei L et al. CD44 regulates the apoptotic response and promotes disease development in chronic lymphocytic leukemia. Blood 2013; 121: 4126\u20134136.","journal-title":"Blood"},{"key":"BFleu2015114_CR20","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","volume":"376","author":"M Hallek","year":"2010","unstructured":"Hallek M, Fischer K, Fingerle-Rowson G, Fink AM, Busch R, Mayer J et al. Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010; 376: 1164\u20131174.","journal-title":"Lancet"},{"key":"BFleu2015114_CR21","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.matbio.2007.04.003","volume":"26","author":"P Spessotto","year":"2007","unstructured":"Spessotto P, Zucchetto A, Degan M, Wasserman B, Danussi C, Bomben R et al. Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. Matrix Biol 2007; 26: 473\u2013484.","journal-title":"Matrix Biol"},{"key":"BFleu2015114_CR22","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd2638","volume":"7","author":"G Hask\u00f3","year":"2008","unstructured":"Hask\u00f3 G, Linden J, Cronstein B, Pacher P . Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 2008; 7: 759\u2013770.","journal-title":"Nat Rev Drug Discov"},{"key":"BFleu2015114_CR23","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1349-7006.2009.01152.x","volume":"100","author":"S Goyama","year":"2009","unstructured":"Goyama S, Kurokawa M . Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies. Cancer Sci 2009; 100: 990\u2013995.","journal-title":"Cancer Sci"},{"key":"BFleu2015114_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2005.09.020","volume":"368","author":"G Nucifora","year":"2006","unstructured":"Nucifora G, Laricchia-Robbio L, Senyuk V . EVI1 and hematopoietic disorders: history and perspectives. Gene 2006; 368: 1\u201311.","journal-title":"Gene"},{"key":"BFleu2015114_CR25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3109\/10428194.2013.764418","volume":"54","author":"A Lanemo Myhrinder","year":"2013","unstructured":"Lanemo Myhrinder A, Hellqvist E, Bergh AC, Jansson M, Nilsson K, Hultman P et al. Molecular characterization of neoplastic and normal \u2018sister\u2019 lymphoblastoid B-cell lines from chronic lymphocytic leukemia. Leuk Lymphoma 2013; 54: 1769\u20131779.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2015114_CR26","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/PAS.0b013e31802e2201","volume":"31","author":"M Herling","year":"2007","unstructured":"Herling M, Patel KA, Hsi ED, Chang KC, Rassidakis GZ, Ford R et al. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage. Am J Surg Pathol 2007; 31: 1123\u20131129.","journal-title":"Am J Surg Pathol"},{"key":"BFleu2015114_CR27","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1084\/jem.20120833","volume":"209","author":"M Seifert","year":"2012","unstructured":"Seifert M, Sellmann L, Bloehdorn J, Wein F, Stilgenbauer S, D\u00fcrig J et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209: 2183\u20132198.","journal-title":"J Exp Med"},{"key":"BFleu2015114_CR28","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1182\/blood-2007-02-071225","volume":"109","author":"ES Raveche","year":"2007","unstructured":"Raveche ES, Salerno E, Scaglione BJ, Manohar V, Abbasi F, Lin YC et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 2007; 109: 5079\u20135086.","journal-title":"Blood"},{"key":"BFleu2015114_CR29","doi-asserted-by":"publisher","first-page":"12210","DOI":"10.1073\/pnas.1007186107","volume":"107","author":"U Santanam","year":"2010","unstructured":"Santanam U, Zanesi N, Efanov A, Costinean S, Palamarchuk A, Hagan JP et al. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci USA 2010; 107: 12210\u201312215.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR30","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1182\/blood-2011-09-381814","volume":"119","author":"M Lia","year":"2012","unstructured":"Lia M, Carette A, Tang H, Shen Q, Mo T, Bhagat G et al. Functional dissection of the chromosome 13q14 tumor-suppressor locus using transgenic mouse lines. Blood 2012; 119: 2981\u20132990.","journal-title":"Blood"},{"key":"BFleu2015114_CR31","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/leu.2010.46","volume":"24","author":"A Efanov","year":"2010","unstructured":"Efanov A, Zanesi N, Nazaryan N, Santanam U, Palamarchuk A, Croce CM et al. CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation. Leukemia 2010; 24: 970\u2013975.","journal-title":"Leukemia"},{"key":"BFleu2015114_CR32","doi-asserted-by":"publisher","first-page":"7413","DOI":"10.1073\/pnas.1304977110","volume":"110","author":"S Volinia","year":"2013","unstructured":"Volinia S, Croce CM . Prognostic microRNA\/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci USA 2013; 110: 7413\u20137417.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR33","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.1073\/pnas.1019557108","volume":"108","author":"E Moussay","year":"2011","unstructured":"Moussay E, Wang K, Cho JH, van Moer K, Pierson S, Paggetti J et al. MicroRNA as biomarkers and regulators in B-cell chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2011; 108: 6573\u20136578.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR34","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.3109\/10428194.2012.763123","volume":"54","author":"G Ferrer","year":"2013","unstructured":"Ferrer G, Navarro A, Hodgson K, Aymerich M, Pereira A, Baumann T et al. MicroRNA expression in chronic lymphocytic leukemia developing autoimmune hemolytic anemia. Leuk Lymphoma 2013; 54: 2016\u20132022.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2015114_CR35","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1182\/blood-2011-01-333484","volume":"118","author":"R Visone","year":"2011","unstructured":"Visone R, Veronese A, Rassenti LZ, Balatti V, Pearl DK, Acunzo M et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood 2011; 118: 3072\u20133079.","journal-title":"Blood"},{"key":"BFleu2015114_CR36","doi-asserted-by":"publisher","first-page":"10175","DOI":"10.1073\/pnas.0704170104","volume":"104","author":"AI Kuraishy","year":"2007","unstructured":"Kuraishy AI, French SW, Sherman M, Herling M, Jones D, Wall R et al. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation. Proc Natl Acad Sci USA 2007; 104: 10175\u201310180.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2015114_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S1079-9796(03)00159-1","volume":"31","author":"S Buonamici","year":"2003","unstructured":"Buonamici S, Chakraborty S, Senyuk V, Nucifora G . The role of EVI1 in normal and leukemic cells. Blood Cells Mol Dis 2003; 31: 206\u2013212.","journal-title":"Blood Cells Mol Dis"},{"key":"BFleu2015114_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.stem.2008.06.002","volume":"3","author":"S Goyama","year":"2008","unstructured":"Goyama S, Yamamoto G, Shimabe M, Sato T, Ichikawa M, Ogawa S et al. Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008; 3: 207\u2013220.","journal-title":"Cell Stem Cell"},{"key":"BFleu2015114_CR39","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1084\/jem.20110447","volume":"208","author":"K Kataoka","year":"2011","unstructured":"Kataoka K, Sato T, Yoshimi A, Goyama S, Tsuruta T, Kobayashi H et al. Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity. J Exp Med 2011; 208: 2403\u20132416.","journal-title":"J Exp Med"},{"key":"BFleu2015114_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1200\/JCO.2011.41.5505","volume":"31","author":"S Gr\u00f6schel","year":"2013","unstructured":"Gr\u00f6schel S, Schlenk RF, Engelmann J, Rockova V, Teleanu V, K\u00fchn MW et al. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON\/SAKK Cooperative Group. J Clin Oncol 2013; 31: 95\u2013103.","journal-title":"J Clin Oncol"},{"key":"BFleu2015114_CR41","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.exphem.2012.05.007","volume":"40","author":"K Shimada","year":"2012","unstructured":"Shimada K, Tomita A, Minami Y, Abe A, Hind CK, Kiyoi H et al. CML cells expressing the TEL\/MDS1\/EVI1 fusion are resistant to imatinib-induced apoptosis through inhibition of BAD, but are resensitized with ABT-737. Exp Hematol 2012; 40: 724\u2013737, e2.","journal-title":"Exp Hematol"},{"key":"BFleu2015114_CR42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1001\/jama.2010.1919","volume":"305","author":"M Fabbri","year":"2011","unstructured":"Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S et al. Association of a microRNA\/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011; 305: 59\u201367.","journal-title":"JAMA"},{"key":"BFleu2015114_CR43","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/j.1541-0420.2008.00995.x","volume":"64","author":"T Hothorn","year":"2008","unstructured":"Hothorn T, Zeileis A . Generalized maximally selected statistics. Biometrics 2008; 64: 1263\u20131269.","journal-title":"Biometrics"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2015114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015114","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2015114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T16:27:34Z","timestamp":1648744054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2015114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,4]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["BFleu2015114"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.114","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,4]]},"assertion":[{"value":"1 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}